Brind.
  1. Calidi Biotherapeutics announced a public offering in San Diego on August 22, 2025, which was subsequently declared effective by the SEC.

Ladenburg Thalmann and Laidlaw & Company co-manage a public offering for Calidi Biotherapeutics.

1 report, 1 independent Updated Aug 20
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Ladenburg Thalmann and Laidlaw & Company co-manage a public offering for Calidi Biotherapeutics.

Who's involved

What this event is mainly about
Ladenburg Thalmann

Keep exploring

Part of

Calidi Biotherapeutics announced a public offering in San Diego on August 22, 2025, which was subsequently declared effective by the SEC. All 2 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireCalidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering SAN DIEGO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “C